Effects of lowering circulating free fatty acid levels on protein metabolism in adult growth hormone deficient patients

Growth Hormone and IGF Research

Volumn 12, Issue 6, 2002, Pages 425-433

  Nielsen, Steen ^a   Jørgensen, Jens O L ^a   Hartmund, Tore ^a   Nørrelund, Helene ^a   Nair, K S ^b   Christiansen, Jens Sandahl ^a   Møller, Niels ^a,c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b MAYO CLINIC   (United States)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Acipimox; Forearm; Phenylalanine; Tracers; Tyrosine

Indexed keywords

ACIPIMOX; AMINO ACID; DESMOPRESSIN; FATTY ACID; FLUDROCORTISONE; GLUCAGON; GROWTH HORMONE; HYDROCORTISONE; INSULIN; MUSCLE PROTEIN; NEUTRAL INSULIN; PHENYLALANINE; SOMATOMEDIN C; STABLE ISOTOPE; TESTOSTERONE; THYROXINE; TYROSINE; UREA; ANTILIPEMIC AGENT; PROTEIN; PYRAZINE DERIVATIVE;

ADULT; AMINO ACID METABOLISM; AMINO ACID TRANSPORT; CATABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; FOREARM; GLUCAGON BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GROWTH HORMONE DEFICIENCY; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; ISOTOPE DILUTION ASSAY; LIPOLYSIS; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW; UREA BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PITUITARY DWARFISM; VASCULARIZATION;

ADULT; ANTILIPEMIC AGENTS; AREA UNDER CURVE; BLOOD GLUCOSE; DWARFISM, PITUITARY; FATTY ACIDS, NONESTERIFIED; FEMALE; FOREARM; GROWTH HORMONE; HUMANS; LIPOLYSIS; MALE; MIDDLE AGED; PHENYLALANINE; PROTEINS; PYRAZINES; TYROSINE; UREA;

EID: 1842837895     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(02)00119-3     Document Type: Article

References (26)

1. Sherwin RS, Hendler RG, Felig P. Effect of ketone infusions on amino acid and nitrogen metabolism in man. J Clin Invest 1975; 55(6): 1382-1390.
2. Tessari P, Nissen SL, Miles JM, Haymond MW. Inverse relationship of leucine flux and oxidation to free fatty acid availability in vivo. J Clin Invest 1986; 77(2): 575-581.
3. Nair KS, Welle SL, Halliday D, Campbell RG. Effect of β-hydroxybutyrate on whole-body leucine kinetics and fractional mixed skeletal muscle protein synthesis in humans. J Clin Invest 1988; 82(1): 198-205.
4. Salomon F, Cuneo RC, Hesp R, Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989; 321(26): 1797-1803.
5. Jorgensen JO, Thuesen L, Muller J, Ovesen P, Skakkebaek NE, Christiansen JS. Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance. Eur J Endocrinol 1994; 130(3): 224-228.
6. Rutherford OM, Jones DA, Round JM, Buchanan CR, Preece MA. Changes in skeletal muscle and body composition after discontinuation of growth hormone treatment in growth hormone deficient young adults. Clin Endocrinol (Oxf) 1991; 34(6): 469-475.
7. Hoffman DM, Pallasser R, Duncan M, Nguyen TV, Ho KK. How is whole body protein turnover perturbed in growth hormone-deficient adults? J Clin Endocrinol Metab 1998; 83(12): 4344-4349.
8. Binnerts A, Swart GR, Willson JH, et al. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol (Oxf) 1992; 37(1): 79-87.
9. Russell-Jones DL, Weissberger AJ, Bowes SB, et al. The effects of growth hormone on protein metabolism in adult growth hormone deficient patients. Clin Endocrinol (Oxf) 1993; 38(4): 427-431.
10. Lucidi P, Lauteri M, Lauteri S, et al. A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults. J Clin Endocrinol Metab 1998; 83(2): 353-357.
11. Møller N, Butler PC, Antsiferov MA, Alberti KGMM. Effects of growth hormone on insulin sensitivity and forearm substrate exchange in normal man. Diabetologia 1989; 32: 105-112.
12. Norrelund H, Nair KS, Jorgensen JOL, Christiansen JS, Moller N. The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein break-down. Diabetes 2001; 50: 96-104.
13. Nair KS, Ford GC, Ekberg K, Fernqvist Forbes E, Wahren J. Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. J Clin Invest 1995; 95(6): 2926-2937.
14. 5]phenylalanine model. Am J Physiol 1989; 256(5 Pt 1): E631-639.
15. Copeland KC, Nair KS. Acute growth hormone effects on amino acid and lipid metabolism. J Clin Endocrinol Metab 1994; 78(5): 1040-1047.
16. Orskov H, Thomsen HG, Yde H. Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature 1968; 219(150): 193-195.
17. Fery F, Plat L, Baleriaux M, Balasse EO. Inhibition of lipolysis stimulates whole body glucose production and disposal in normal postabsorptive subjects. J Clin Endocrinol Metab 1997; 82(3): 825-830.
18. Walker M, Shmueli E, Daley SE, Cooper G, Alberti KGMM. Do nonesterified fatty acids regulate skeletal muscle turnover in humans? Am J Physiol 1993; 265: E357-E361.
19. Charlton MR, Nair KS. Role of hyperglucagonemia in catabolism associated with type 1 diabetes: effects on leucine metabolism and the resting metabolic rate. Diabetes 1998; 47: 1748-1756.
20. Vilstrup H, Hansen BA, Almdal TP. Glucagon increases hepatic efficacy for urea synthesis. J Hepatol 1990; 10: 46-50.
21. Bengtsson BA, Eden S, Lonn L, et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993; 76(2): 309-317.
22. Amato G, Carella C, Fazio S, et al. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab 1993; 77(6): 1671-1676.
23. Fryburg DA, Gelfand RA, Barrett EJ. Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am J Physiol 1991; 260(3 Pt 1): E499-E504.
24. Fryburg DA, Louard RJ, Gerow KE, Gelfand RA, Barrett EJ. Growth hormone stimulates skeletal muscle protein synthesis and antagonizes insulin's antiproteolytic action in humans. Diabetes 1992; 41(4): 424-429.
25. Horber FF, Haymond MW. Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest 1990; 86(1): 265-272.
26. Mauras N, O'Brien KO, Welch S, Rini A, Helgeson K, Vieira NE, Yergey AL. Insulin-like growth factor I and growth hormone (GH) treatment in GH deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism. J Clin Endocrinol Metab 2000; 85: 1886-1894.